Back

Time to benefit of antibacterial envelope use to prevent cardiac implantable device infection: a meta-analysis of reconstructed individual patient data

12 April 2026 (08:00 - 15:30)
Organised by: Logo
Congress Presentation Part of: Device complications and lead extraction Device Complications and Lead Extraction EHRA Premium Access EHRA 2026 European Heart Rhythm Association (EHRA)

About the speaker

Photo
Miss Lara Guedes

(Brazil)

6 More presentations in this session

Presentation thumbnail
Distance from pacing lead tip to left ventricular cavity predicts loss of left bundle branch capture: insights from the IMAGE-LBBP cohort with long-term follow-up
Doctor M. Cai (Beijing, CN)
Abstract Slides Video
Presentation thumbnail
Cost-effectiveness modeling of early lead extraction for cardiac implantable electronic device infections in the United Kingdom
Professor A. Rinaldi (London, GB)
Abstract Slides Video
Presentation thumbnail
Early- and long-term outcomes in patients with cardiac implantable electronic devices undergoing radiation therapy
Doctor J. Machowicz (Zabrze, PL)
Abstract Slides Video
Presentation thumbnail
Comparative analysis of pacing-induced cardiomyopathy (picm) between leadless and transvenous pacemakers: a 10-year experience from a southeast asian national heart centre
Doctor N. Atan (Kuala Lumpur, MY)
Abstract Slides Video
Presentation thumbnail
Clavipectoral optimized motor-sparing fascial block for tolerable cardiac implantable electronic device procedures- COMFORT-CIED
Doctor Y. YAMANTURK (Ankara, TR)
Abstract Slides Video

Access the full session

Session thumbnail
Device complications and lead extraction

The Event

Event poster

EHRA 2026

12 April - 14 April 2026
You may be interested in
thumbnail
Congress Presentation
Antibacterial devices efficacy in high-risk CIED recipients: propensity score matching analysis.
thumbnail
Congress Presentation
Postoperative antibiotic prophylaxis following cardiac implantable electronic device implantation and the risk of device infection
thumbnail
Congress Presentation
Tauropace reduces infections in patients with heart failure and reduced ejection fraction after cardiac electronic implantable device implantation.

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources